Investigating the link between obstructive sleep apnea and Alzheimer's disease
Official title: Is Obstructive Sleep Apnea Important in the Development of Alzheimer's Disease
Funded at University of California, San Diego · NIH-10861744 · Data updated 2026-11-12
This study is looking at how sleep apnea might be linked to Alzheimer's disease in older adults, and it aims to find out if oxygen therapy can help improve thinking skills for those affected.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project start | June 1, 2020 |
| Project end | April 30, 2026 |
| Funding year | 2024 |
| Award (this year) | $728,661 |
| NIH project number | 5R01AG063925-05 |
| Project ID | NIH-10861744 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are older adults who have been diagnosed with obstructive sleep apnea and are at risk for developing Alzheimer's disease.
✕Less likely to help
Patients who do not have obstructive sleep apnea or those who are not at risk for Alzheimer's disease may not benefit from this research.
What this research studies
This research explores how obstructive sleep apnea (OSA), a condition that disrupts breathing during sleep, may contribute to the development of Alzheimer's disease, particularly in older adults. The study aims to understand the mechanisms behind this connection, including the roles of oxidative stress and the accumulation of amyloid and tau proteins in the brain. By using innovative, minimally invasive methods, researchers will assess the pathophysiology of OSA and its impact on cognitive functions. The project will also evaluate the effectiveness of oxygen therapy in OSA patients who are at risk for Alzheimer's, with the goal of improving cognitive outcomes.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for preventing or mitigating Alzheimer's disease in patients with obstructive sleep apnea.
How similar studies have gone: Other research has indicated a potential link between sleep disorders and cognitive decline, suggesting that this approach may yield valuable insights.
Where this research is happening
-
University of California, San Diego
La Jolla, United States Active
Researchers
- Principal investigator: Malhotra, Atul — University of California, San Diego
- Study coordinator: Malhotra, Atul
Related research
Other NIH-funded projects on the same topics.
-
Understanding how sleep apnea may raise Alzheimer’s risk in older Black adults
This project looks at why sleep apnea might help explain why older Black people have a higher risk of Alzheimer’s disease.
-
Investigating the link between obstructive sleep apnea and Alzheimer's disease risk in older Black individuals
This study is looking at how sleep apnea might increase the risk of Alzheimer's disease in older Black adults, focusing on how sleep patterns and inflammation play a role, with the goal of finding better ways to support those at risk.
-
Sleep Apnea, Memory, and Alzheimer's Disease in World Trade Center Responders
This project looks at how sleep apnea might be connected to memory changes and early signs of Alzheimer's disease in people who responded to the World Trade Center events.
-
Investigating how sleep apnea affects cognition and Alzheimer's disease in World Trade Center responders
This study is looking at how sleep apnea might affect thinking and memory in people who were exposed to World Trade Center dust, to see if improving sleep could help lower the risk of developing Alzheimer's disease.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.